SUNNYVALE, Calif.--(BUSINESS WIRE)--Corsair Pharma, Inc., a private biopharmaceutical company developing a transdermal treprostinil prodrug, today announced the appointment of George W. Mahaffey as Chief Executive Officer. He will also serve as a Director of the Company. Mr. Mahaffey brings more than 35 years of pha...